Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov-Dec;9(6):463-9.

In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca

Affiliations

In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca

M Behbahani et al. Res Pharm Sci. 2014 Nov-Dec.

Abstract

Previously, we reported that the kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca showed potent anti-HSV activity. In the present study the anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside are investigated at different concentrations (100, 50, 25 and 10 μg/ml) using HIV-1 p24 Antigen kit. Real-time Polymerase chain reaction (RT-PCR) assay was also used for quantification of full range of virus load observed in treated and untreated cells. According to the results of RT- PCR, tested compounds at a concentration of 100 μg/ml exerted potent inhibitory effect. Time of drug addition experiments demonstrated that these compounds exerted their inhibitory effects on the early stage of HIV infection. The results also showed potent anti-HIV-1 reverse transcriptase activity. Antiviral activity of kaempferol-7-O-glucoside was more pronounced than that of kaempferol. These findings demonstrate that kaempferol-7-O-glucoside could be considered as a new potential drug candidate for the treatment of HIV infection which requires further assessments.

Keywords: Antiviral activity; Flavonol; HIV-1; Real Time PCR assay.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of kaempferol and kaempferol-7-O-glucoside isolated from S. securidaca and zidovudine on HIV-1 replication in peripheral blood mononuclear cells. The 50% inhibitory concentration (IC50) of each extract was calculated using regression line. Each bar represents the mean ± SD of three independent experiments.
Fig. 2
Fig. 2
Effect of Kaempferol (◊) and Kaempferol-7-O-glucoside (□) on proliferation of lymphocyte
Fig. 3
Fig. 3
Time of addition effect of kaempferol (white bar) and kaempferol-7-O-glucoside (gray bar) obtained from S. securidaca on HIV replication in Vero cells. The extracts was added either before (−2 and −4), during (0) and after (2 and 4) virus infection. The extracts added before virus infection was rinsed off prior to the virus exposure. Each value is the result of mean ± SD of three independent experiments. Zidovudine has been used as positive control (hatched bar).
Fig. 4
Fig. 4
HIV-1 reverse transcriptase inhibition by kaempferol and kaempferol-7-O-glucoside isolated from S. securigera The data represent the mean HIV-1 reverse transcriptase inhibition of extracts. The reverse transcriptase inhibitions of extracts are the mean of three separate experiments.

References

    1. Bessong PO, Obi CL. Ethnopharmacology of human immunodeficiency virus in south Africa minireview. African j biotechnol. 2006;5:1693–1699.
    1. Vermani K, Garg S. Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharm. 2005;80:49–66. - PubMed
    1. Rates SM. Plants as source of drugs. Toxicon. 2001;39:603–613. - PubMed
    1. Singh IP, Bharate SB, Bhutani KK. Anti-HIV natural products. Curr Sci. 2005;89:269–291.
    1. Wang RR, Gu Q, Yang LM, Chen JJ, Li SY, Zheng YT. Anti-HIV-1 activities of extracts from the medical plant Rhus chinensis. Ethnopharm. 2006;105:269–273. - PubMed

LinkOut - more resources